• Title of article

    Effect of Intensive Lifestyle Changes on Endothelial Function and on Inflammatory Markers of Atherosclerosis

  • Author/Authors

    Dod، نويسنده , , Harvinder S. and Bhardwaj، نويسنده , , Ravindra and Sajja، نويسنده , , Venu and Weidner، نويسنده , , Gerdi and Hobbs، نويسنده , , Gerald R. and Konat، نويسنده , , Gregory W. and Manivannan، نويسنده , , Shanthi and Gharib، نويسنده , , Wissam and Warden، نويسنده , , Bradford E. and Nanda، نويسنده , , Navin C. and Beto، نويسنده , , Robert J. and Ornish، نويسنده , , Dean and Jain، نويسنده , , Ab، نويسنده ,

  • Issue Information
    روزنامه با شماره پیاپی سال 2010
  • Pages
    6
  • From page
    362
  • To page
    367
  • Abstract
    Intensive lifestyle changes have been shown to regress atherosclerosis, improve cardiovascular risk profiles, and decrease angina pectoris and cardiac events. We evaluated the influence of the Multisite Cardiac Lifestyle Intervention Program, an ongoing health insurance-covered lifestyle intervention conducted at our site, on endothelial function and inflammatory markers of atherosclerosis in this pilot study. Twenty-seven participants with coronary artery disease (CAD) and/or risk factors for CAD (nonsmokers, 14 men; mean age 56 years) were enrolled in the experimental group and asked to make changes in diet (10% calories from fat, plant based), engage in moderate exercise (3 hours/week), and practice stress management (1 hour/day). Twenty historically (age, gender, CAD, and CAD risk factors) matched participants were enrolled in the control group with usual standard of care. At baseline endothelium-dependent brachial artery flow-mediated dilatation (FMD) was performed in the 2 groups. Serum markers of inflammation, endothelial dysfunction, and angiogenesis were performed only in the experimental group. After 12 weeks, FMD had improved in the experimental group from a baseline of 4.23 ± 0.13 to 4.65 ± 0.15 mm, whereas in the control group it decreased from 4.62 ± 0.16 to 4.48 ± 0.17 mm. Changes were significantly different in favor of the experimental group (p <0.0001). Also, significant decreases occurred in C-reactive protein (from 2.07 ± 0.57 to 1.6 ± 0.43 mg/L, p = 0.03) and interleukin-6 (from 2.52 ± 0.62 to 1.23 ± 0.3 pg/ml, p = 0.02) after 12 weeks. Significant improvement in FMD, C-reactive protein, and interleukin-6 with intensive lifestyle changes in the experimental group suggests ≥1 potential mechanism underlying the clinical benefits seen in previous trials.
  • Journal title
    American Journal of Cardiology
  • Serial Year
    2010
  • Journal title
    American Journal of Cardiology
  • Record number

    1898845